During the past decade, Instituto de Retina de Lisboa conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Retina de Lisboa" #1 collaborator was "European Vision Institute Clinical Research Network" with 2 trials as a collaborator, "Alpha Bioresearch S.L." with 1 trials as a collaborator and "Investigación Estadística" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Retina de Lisboa" are "Diabetic Macular Edema" (2 trials), "High Risk Proliferative Diabetic Retinopathy" (2 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Instituto de Retina de Lisboa" in a lesser frequency.

Most popular intervention types in "Instituto de Retina de Lisboa" are "Drug" (4 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intravitreous injection of ranibizumab" (2 trials), "Panretinal Photocoagulation (PRP)" (2 trials), "IlUVIEN" (1 trials), "Ozurdex" (1 trials) and "Retilut" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Retina de Lisboa" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Retina de Lisboa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Instituto de Retina de Lisboa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Retina de Lisboa, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".